Laurus Labs: Update on equity investment in KRKA Pharma Private Limited
Laurus Labs (LAURUSLABS) filed a disclosure titled "Update on equity investment in KRKA Pharma Private Limited". The company is valued at about ₹1.1 lakh crore.
What happened
Laurus Labs (LAURUSLABS) filed a disclosure with the exchanges on 14 October 2026 at 08:09 PM titled "Update on equity investment in KRKA Pharma Private Limited".
Company snapshot
Laurus Labs is a large-cap company in the Healthcare sector, with a market value of about ₹1.1 lakh crore.
The stock last traded at ₹2,036.9, against a 52-week range of ₹864.7–₹2,069.2 (1.6% below the high).
Before this filing the shares had moved +5.1% over the month and +33.1% over three months. Average daily turnover over the last 20 sessions was about ₹319 crore.
Promoters held 27.47% at the end of Q1 FY27, down 0.02% points from the previous quarter; 2.69% of promoter shares were pledged. Foreign institutions owned 28.00% and domestic institutions 13.74%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,570 | 163 | 3.02 |
| Q2 FY26 | 3,223 | 358 | 6.63 |
| Q3 FY26 | 1,778 | 251.7 | 4.67 |
| Q4 FY26 | 1,812 | 279.1 | 5.17 |
| Q1 FY27 | 2,026 | 367.6 | 6.81 |
What history shows
This is not the company's first corporate update disclosure: BCEIE has 4 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.7% on average the next trading day and was up 8.9% on average after five days (2 filings with price data).
Across 5 similar disclosures by other Healthcare companies, shares moved −1.4% on average the next day and −4.9% over five days; 60% of them rose the next day.
Market-wide, 204 corporate update filings with an impact score of 50 or more saw an average next-day move of −0.5%, with 37% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 24 Jul 2026 | Corporate update | +9.3% | +15.8% |
| 6 Jul 2026 | Completion Of Tenure Of Independent Director | −3.9% | +2.1% |
What to watch
- 29 October 2026: Board meeting — Financial Results/Dividend.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.